3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Breast Neoplasms
944
Neoplasms
713
Prostatic Neoplasms
498
Lung Neoplasms
402
Colorectal Neoplasms
363
Carcinoma, Non-Small-Cell Lung
362
Leukemia, Myeloid, Acute
290
Pancreatic Neoplasms
239
Brain Neoplasms
230
Neoplasm Metastasis
225
Multiple Myeloma
218
Carcinoma, Hepatocellular
202
Head and Neck Neoplasms
187
Glioblastoma
183
Precursor Cell Lymphoblastic Leukemia-Lymphoma
181
Melanoma
177
Ovarian Neoplasms
170
Squamous Cell Carcinoma of Head and Neck
161
Rectal Neoplasms
145
Uterine Cervical Neoplasms
144
Recurrence
143
Hematologic Neoplasms
137
Sarcoma
136
Glioma
132
Stomach Neoplasms
129
Triple Negative Breast Neoplasms
127
Carcinoma, Renal Cell
126
Myelodysplastic Syndromes
114
Colonic Neoplasms
113
Esophageal Neoplasms
111
Interventions
Sodium Iodide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thyroid cancer, Hurthle cell
×
90 days
×
Clear all
NCT01398085
2026-05-07
IoN
University College, London
Phase 2/3
Active not recruiting
504 enrolled